Horizon 2020 SME-Instrument topic: clinical research for the validation of biomarkers and/or diagnostic medical devices
Abstract
The European Commission released €130 million over 2014, 2015 and 2017 under the EU Framework Program for Research and Innovation, Horizon 2020, to support innovative small and medium-sized enterprises in the diagnostic area. The call topic focused on ‘Clinical research for the validation of biomarkers and/or diagnostic medical devices’. It attracted 1194 applicants from all over Europe. The quality of the proposals was high and a large proportion of them were eligible for funding. In the majority, proposals were about in vitro diagnostics and tackled both clinical validation of new biomarkers and device optimization. The proposals dealt with various advanced technologies. One third of the proposers gave priority to the new and promising field of personalized medicine.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 The new regulations on medical devices. https://ec.europa.eu/growth/sectors/medical-devices/regulatory-framework_en. • Detailed official information about the new European regulatory framework of medical devices.
- 2 What is an SME? http://ec.europa.eu/growth/smes/business-friendly-environment/sme-definition_is.
- 3 MedTech Europe. The European medical technology industry in figures. Report 2016. www.medtecheurope.org/.
- 4 . Bring on the biomarkers. Nature 469, 156–157 (2011).
- 5 The EU Framework Programme for Research and Innovation (Horizon 2020). https://ec.europa.eu/programmes/horizon2020.
- 6 H2020-SMEINST-2014–2015. http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-smeinst-2014–2015.html.
- 7 Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 38, 3 (2001).
- 8 The SME Instrument. http://ec.europa.eu/programmes/horizon2020/en/h2020-section/sme-instrument.
- 9 SME Instrument Report: Catalysing European Innovation (EASME's report of the first two years of implementation of the SME Instrument. www.octopux.eu/new/wp-content/uploads/2016/11/catalysing_european_innovation_-_easmes_report_of_the_first_two_years_of_implementation_of_the_sme_instrument_2014–2015.pdf. •• A thorough analysis of the first 2 years of implementation of the SME Instrument and it is not limited to health.
- 10 Venture Radar. http://about.ventureradar.com/.
- 11 . Existing and emerging technologies for point-of-care testing. Clin. Biochem. Rev. 35(3), 155–167 (2014).
- 12 Elsevier's bibliographic database Scopus®. www.elsevier.com/solutions/scopus.
- 13 Mobile technology and the digitization of healthcare. Eur. Heart J. 37, 1428–1438 (2016).
- 14 Visiongain. The Companion Diagnostics (CDx) Market Forecast 2016–2026. www.visiongain.com/Report/1614/The-Companion-Diagnostics-(CDx)-Market-Forecast-2016–2026.
- 15 ICD-10, Version 2016. www.who.int/classifications/icd/en/.
- 16 World Health Organization. The global burden of disease: 2004 update. www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf?ua=1. • Extensive analysis of disease burden worldwide published in 2008.
